EPS from L‐14 extract inhibits adipogenesis via TLR2 and AMPK signalling pathways, and oral intake of L‐14 extract improves obesity and obesity‐associated diseases in vivo. The gene discussed is TLR2; the disease is obesity due to melanocortin 4 receptor deficiency.